Provided by Tiger Trade Technology Pte. Ltd.

Macrogenics

1.75
+0.05002.94%
Post-market: 1.60-0.1500-8.57%19:55 EST
Volume:426.73K
Turnover:743.34K
Market Cap:110.70M
PE:-1.45
High:1.78
Open:1.70
Low:1.70
Close:1.70
52wk High:2.93
52wk Low:0.9897
Shares:63.26M
Float Shares:52.66M
Volume Ratio:1.88
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2097
EPS(LYR):-1.0694
ROE:-81.13%
ROA:-26.52%
PB:1.65
PE(LYR):-1.64

Loading ...

BRIEF-Macrogenics Announces Pausing Of Enrollment Of New Study Participants In Linnet Trial

Reuters
·
3 hours ago

FDA places partial clinical hold on MacroGenics’ Phase 2 LINNET trial enrollment

Reuters
·
4 hours ago

MacroGenics Announces Pausing of Enrollment of New Study Participants in Linnet Trial

THOMSON REUTERS
·
4 hours ago

MacroGenics Inc: U. S. Food and Drug Administration (FDA) Has Placed a Partial Clinical Hold on Its Phase 2 Linnet Study of Lorigerlimab

THOMSON REUTERS
·
4 hours ago

MacroGenics Inc: Current Study Participants May Continue to Receive Study Drug

THOMSON REUTERS
·
4 hours ago

MacroGenics: FDA's Partial Clinical Hold Initiated After Co's Notification to FDA of Temporary Pause in Enrollment of New Participants in Linnet Trial

THOMSON REUTERS
·
4 hours ago

MacroGenics Chief Medical Officer Stephen Eck to Depart End of 2025

Reuters
·
Nov 21, 2025

MacroGenics Q3 Net Income USD 16.8 Million

Reuters
·
Nov 20, 2025

Macrogenics Q3 EPS $0.27 Beats $(0.58) Estimate, Sales $72.839M Beat $14.700M Estimate

Benzinga
·
Nov 13, 2025

MacroGenics Q3 revenue declines, secures $75 mln in partnerships

Reuters
·
Nov 13, 2025

BRIEF-MacroGenics Q3 Net Income USD 16.8 Million

Reuters
·
Nov 13, 2025

MacroGenics Inc - Extends Cash Runway Guidance Into Late 2027

THOMSON REUTERS
·
Nov 13, 2025

Top News Today/Canada: Barrick's Interim CEO Gets to Work

Dow Jones
·
Nov 11, 2025

MacroGenics Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

MacroGenics CEO to Join Stifel Healthcare Conference

Reuters
·
Nov 07, 2025

Macrogenics Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

Dow Jones
·
Nov 03, 2025

MacroGenics Inc expected to post a loss of 45 cents a share - Earnings Preview

Reuters
·
Oct 31, 2025

Barclays Initiates a Buy Rating on MacroGenics (MGNX)

TIPRANKS
·
Sep 19, 2025

MacroGenics (MGNX) Initiated with a Buy at Roth MKM

TIPRANKS
·
Sep 17, 2025

Macrogenics Coverage Assumed by Barclays at Overweight

Dow Jones
·
Sep 17, 2025